TVTX - Travere Therapeutics Non-GAAP EPS of $1.51 beats by $2.30 revenue of $41.37M misses by $2.25M
2024-05-06 16:04:30 ET
More on Travere Therapeutics
- Travere Therapeutics, Inc. (TVTX) Q4 2023 Earnings Call Transcript
- Travere Therapeutics Q1 2024 Earnings Preview
- Travere, CSL win conditional nod for kidney disease therapy in EU
- Seeking Alpha’s Quant Rating on Travere Therapeutics
- Historical earnings data for Travere Therapeutics